Cargando…
Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
BACKGROUND: Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse. AIM: To investigate the prevalence, outcome and risk factors for AILD in cirrhotic patients compli...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453760/ https://www.ncbi.nlm.nih.gov/pubmed/36159019 http://dx.doi.org/10.3748/wjg.v28.i31.4417 |
_version_ | 1784785210369376256 |
---|---|
author | Shen, Zi-Xuan Wu, Dan-Dan Xia, Jie Wang, Xian-Bo Zheng, Xin Huang, Yan Li, Bei-Ling Meng, Zhong-Ji Gao, Yan-Hang Qian, Zhi-Ping Liu, Feng Lu, Xiao-Bo Shang, Jia Yan, Hua-Dong Zheng, Yu-Bao Gu, Wen-Yi Zhang, Yan Wei, Jian-Yi Tan, Wen-Ting Hou, Yi-Xin Zhang, Qun Xiong, Yan Zou, Cong-Cong Chen, Jun Huang, Ze-Bing Jiang, Xiu-Hua Luo, Sen Chen, Yuan-Yuan Gao, Na Liu, Chun-Yan Yuan, Wei Mei, Xue Li, Jing Li, Tao Zhou, Xin-Yi Deng, Guo-Hong Chen, Jin-Jun Ma, Xiong Li, Hai |
author_facet | Shen, Zi-Xuan Wu, Dan-Dan Xia, Jie Wang, Xian-Bo Zheng, Xin Huang, Yan Li, Bei-Ling Meng, Zhong-Ji Gao, Yan-Hang Qian, Zhi-Ping Liu, Feng Lu, Xiao-Bo Shang, Jia Yan, Hua-Dong Zheng, Yu-Bao Gu, Wen-Yi Zhang, Yan Wei, Jian-Yi Tan, Wen-Ting Hou, Yi-Xin Zhang, Qun Xiong, Yan Zou, Cong-Cong Chen, Jun Huang, Ze-Bing Jiang, Xiu-Hua Luo, Sen Chen, Yuan-Yuan Gao, Na Liu, Chun-Yan Yuan, Wei Mei, Xue Li, Jing Li, Tao Zhou, Xin-Yi Deng, Guo-Hong Chen, Jin-Jun Ma, Xiong Li, Hai |
author_sort | Shen, Zi-Xuan |
collection | PubMed |
description | BACKGROUND: Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse. AIM: To investigate the prevalence, outcome and risk factors for AILD in cirrhotic patients complicated with AD in China. METHODS: We collected data from patients with cirrhosis and AD from two prospective, multicenter cohorts in hepatitis B virus endemic areas. Patients were regularly followed up at the end of 28-d, 90-d and 365-d, or until death or liver transplantation (LT). The primary outcome in this study was 90-d LT-free mortality. Acute-on-chronic liver failure (ACLF) was assessed on admission and during 28-d hospitalization, according to the diagnostic criteria of the European Association for the Study of the Liver (EASL). Risk factors for death were analyzed with logistic regression model. RESULTS: In patients with cirrhosis and AD, the overall prevalence of AILD was 9.3% (242/2597). Prevalence of ACLF was significantly lower in AILD cases (14%) than those with all etiology groups with cirrhosis and AD (22.8%) (P < 0.001). Among 242 enrolled AILD patients, the prevalence rates of primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and PBC-AIH overlap syndrome (PBC/AIH) were 50.8%, 28.5% and 12.0%, respectively. In ACLF patients, the proportions of PBC, AIH and PBC/AIH were 41.2%, 29.4% and 20.6%. 28-d and 90-d mortality were 43.8% and 80.0% in AILD-related ACLF. The etiology of AILD had no significant impact on 28-d, 90-d or 365-d LT-free mortality in patients with cirrhosis and AD in both univariate and multivariate analysis. Total bilirubin (TB), hepatic encephalopathy (HE) and blood urea nitrogen (BUN) were independent risk factors for 90-d LT-free mortality in multivariate analysis. The development of ACLF during hospitalization only independently correlated to TB and international normalized ratio. CONCLUSION: AILD was not rare in hospitalized patients with cirrhosis and AD in China, among which PBC was the most common etiology. 90-d LT-free mortality were independently associated with TB, HE and BUN. |
format | Online Article Text |
id | pubmed-9453760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-94537602022-09-23 Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China Shen, Zi-Xuan Wu, Dan-Dan Xia, Jie Wang, Xian-Bo Zheng, Xin Huang, Yan Li, Bei-Ling Meng, Zhong-Ji Gao, Yan-Hang Qian, Zhi-Ping Liu, Feng Lu, Xiao-Bo Shang, Jia Yan, Hua-Dong Zheng, Yu-Bao Gu, Wen-Yi Zhang, Yan Wei, Jian-Yi Tan, Wen-Ting Hou, Yi-Xin Zhang, Qun Xiong, Yan Zou, Cong-Cong Chen, Jun Huang, Ze-Bing Jiang, Xiu-Hua Luo, Sen Chen, Yuan-Yuan Gao, Na Liu, Chun-Yan Yuan, Wei Mei, Xue Li, Jing Li, Tao Zhou, Xin-Yi Deng, Guo-Hong Chen, Jin-Jun Ma, Xiong Li, Hai World J Gastroenterol Observational Study BACKGROUND: Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse. AIM: To investigate the prevalence, outcome and risk factors for AILD in cirrhotic patients complicated with AD in China. METHODS: We collected data from patients with cirrhosis and AD from two prospective, multicenter cohorts in hepatitis B virus endemic areas. Patients were regularly followed up at the end of 28-d, 90-d and 365-d, or until death or liver transplantation (LT). The primary outcome in this study was 90-d LT-free mortality. Acute-on-chronic liver failure (ACLF) was assessed on admission and during 28-d hospitalization, according to the diagnostic criteria of the European Association for the Study of the Liver (EASL). Risk factors for death were analyzed with logistic regression model. RESULTS: In patients with cirrhosis and AD, the overall prevalence of AILD was 9.3% (242/2597). Prevalence of ACLF was significantly lower in AILD cases (14%) than those with all etiology groups with cirrhosis and AD (22.8%) (P < 0.001). Among 242 enrolled AILD patients, the prevalence rates of primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and PBC-AIH overlap syndrome (PBC/AIH) were 50.8%, 28.5% and 12.0%, respectively. In ACLF patients, the proportions of PBC, AIH and PBC/AIH were 41.2%, 29.4% and 20.6%. 28-d and 90-d mortality were 43.8% and 80.0% in AILD-related ACLF. The etiology of AILD had no significant impact on 28-d, 90-d or 365-d LT-free mortality in patients with cirrhosis and AD in both univariate and multivariate analysis. Total bilirubin (TB), hepatic encephalopathy (HE) and blood urea nitrogen (BUN) were independent risk factors for 90-d LT-free mortality in multivariate analysis. The development of ACLF during hospitalization only independently correlated to TB and international normalized ratio. CONCLUSION: AILD was not rare in hospitalized patients with cirrhosis and AD in China, among which PBC was the most common etiology. 90-d LT-free mortality were independently associated with TB, HE and BUN. Baishideng Publishing Group Inc 2022-08-21 2022-08-21 /pmc/articles/PMC9453760/ /pubmed/36159019 http://dx.doi.org/10.3748/wjg.v28.i31.4417 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Observational Study Shen, Zi-Xuan Wu, Dan-Dan Xia, Jie Wang, Xian-Bo Zheng, Xin Huang, Yan Li, Bei-Ling Meng, Zhong-Ji Gao, Yan-Hang Qian, Zhi-Ping Liu, Feng Lu, Xiao-Bo Shang, Jia Yan, Hua-Dong Zheng, Yu-Bao Gu, Wen-Yi Zhang, Yan Wei, Jian-Yi Tan, Wen-Ting Hou, Yi-Xin Zhang, Qun Xiong, Yan Zou, Cong-Cong Chen, Jun Huang, Ze-Bing Jiang, Xiu-Hua Luo, Sen Chen, Yuan-Yuan Gao, Na Liu, Chun-Yan Yuan, Wei Mei, Xue Li, Jing Li, Tao Zhou, Xin-Yi Deng, Guo-Hong Chen, Jin-Jun Ma, Xiong Li, Hai Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China |
title | Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China |
title_full | Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China |
title_fullStr | Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China |
title_full_unstemmed | Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China |
title_short | Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China |
title_sort | prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in china |
topic | Observational Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453760/ https://www.ncbi.nlm.nih.gov/pubmed/36159019 http://dx.doi.org/10.3748/wjg.v28.i31.4417 |
work_keys_str_mv | AT shenzixuan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT wudandan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT xiajie prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT wangxianbo prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT zhengxin prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT huangyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT libeiling prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT mengzhongji prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT gaoyanhang prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT qianzhiping prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT liufeng prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT luxiaobo prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT shangjia prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT yanhuadong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT zhengyubao prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT guwenyi prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT zhangyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT weijianyi prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT tanwenting prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT houyixin prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT zhangqun prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT xiongyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT zoucongcong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT chenjun prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT huangzebing prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT jiangxiuhua prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT luosen prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT chenyuanyuan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT gaona prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT liuchunyan prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT yuanwei prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT meixue prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT lijing prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT litao prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT zhouxinyi prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT dengguohong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT chenjinjun prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT maxiong prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina AT lihai prevalenceandclinicalcharacteristicsofautoimmuneliverdiseaseinhospitalizedpatientswithcirrhosisandacutedecompensationinchina |